Viral Vector Production

TransIT-VirusGEN® GMP Transfection Reagent is designed to enhance delivery of packaging and transfer vector DNA to suspension and adherent HEK 293 cell types in order to increase production of recombinant lentivirus and adeno-associated virus (AAV). Key benefits of TransIT-VirusGEN® GMP Transfection Reagent include:

  • Performance – Efficient DNA delivery for large-scale production of high-titer viral vectors
  • Quality – GMP manufactured and tested for appearance, identity, sterility, endotoxin and mycoplasma
  • Flexibility – Compatible with different virus production platforms and repeat filtration
  • Animal Origin Free – Fully synthetic transfection reagent formulation
With industry-leading performance in high-titer virus manufacturing, TransIT-VirusGEN® GMP offers a simplified, cost-effective workflow, making it the superior choice for large-scale therapeutic virus production.

Ready to take your vector manufacturing to the next level? Contact us about evaluating TransIT-VirusGEN® Transfection Reagent: sales&


Compare TransIT-VirusGEN® Transfection Reagents

Therapeutic Development Pipeline Research & Development Preclinical & Process Development Clinical Trial & Commercial Manufacturing
TransIT-VirusGEN® Reagents      
Composition Identical TransIT-VirusGEN® Reagent Formulation
Ready to use, chemically defined, animal origin free in 77.5% ethanol

Request More Information

Not ready to sample, but interested in learning more? Complete the form below and one of our specialists will contact you. Thank you for your interest in TransIT-VirusGEN® GMP Transfection Reagent.
This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.